Year: 2024
Type: review
Source: European Journal of Cancer
Authors: Mark Lawler, Peter Keeling, Olga Kholmanskikh, Warnyta Minnaard, Heike Moehlig-Zuttermeister, Nicola Normanno, Reena Philip, Claudia Popp, Roberto Salgado, Ademi E. Santiago-Walker, Ana Trullas, Sahar B. van Waalwijk van Doorn-Khosrovani, Richard Vart, Jessica Vermeulen, Marianna Vitaloni, Jaap Verweij
Institutions: Queen's University Belfast, TÜV SÜD (Germany), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, United States Food and Drug Administration, F. Hoffmann-La Roche AG, Peter MacCallum Cancer Centre, Peter MacCallum Cancer Foundation, Janssen Research & Development (United States), European Medicines Agency, Leiden University Medical Center, Janssen (Netherlands)
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: bronze
Awards: G2328232902, G3679001064, G6364779609
OpenAlex ID: W4400663683
